Inovio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $116 | $0 | $100 | $0 |
Gross Profit | 116 | -727 | -759 | |
EBITDA | -18,605 | -24,399 | -31,408 | -29,532 |
EBIT | -19,381 | -25,165 | -32,237 | -30,292 |
Net Income | -19,381 | -25,165,478 | -32,237 | -30,469 |
Net Change In Cash | 116 | 0 | 100 | 0 |
Free Cash Flow | -19,663 | -84,355,186 | -28,661 | -28,795 |
Cash | 65,813 | 21,687 | 34,392 | 19,601 |
Basic Shares | 27,650 | 28,140 | 27,197 | 23,291 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $217 | $832 | $10,262 | $1,774 |
Gross Profit | 217 | -2,671 | 4,766 | -2,956 |
EBITDA | -103,946 | -130,391 | -270,902 | -296,557 |
EBIT | -107,076 | -133,894 | -276,398 | -301,287 |
Net Income | -107,254 | -135,117 | -287,664 | -305,384 |
Net Change In Cash | 217 | 832 | 10,262 | 1,774 |
Cost of Revenue | -24,788 | -179,554 | ||
Free Cash Flow | -104,076,553 | -124,686 | -217,184 | -216,939 |
Cash | 65,813,297 | 14,310 | 46,329 | 71,143 |
Basic Shares | 27,160 | 22,173 | 19,885 | 17,402 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.60 |
2024-09-30 | -$0.89 |
2024-06-30 | -$1.19 |
2024-03-31 | -$1.31 |
